Skip to main content
. 2021 May 15;13(5):5412–5419.

Table 1.

General data

Early-stage endometrial carcinoma χ2/t P-value Atypical endometrial hyperplasia χ2/t P-value


The control group (n=25) The combination group (n=31) The control group (n=20) The combination group (n=27)
Age 0.0096 0.9217 0.0207 0.8857
    <32 15 (60.0) 19 (61.3) 13 (65.0) 17 (62.9)
    ≥32 10 (40.0) 12 (38.7) 7 (35.0) 10 (27.5)
BMI (kg/m2) 0.0577 0.8102 0.1231 0.7257
    <30 17 (68.0) 22 (70.9) 15 (75.0) 19 (70.4)
    ≥30 8 (32.0) 9 (29.1) 5 (25.0) 8 (29.6)
Abnormal menstruation 0.0075 0.9307 0.0026 0.9592
    Yes 14 (56.0) 17 (54.8) 12 (60.0) 16 (59.3)
    No 11 (44.0) 14 (35.2) 8 (40.0) 11 (40.7)
Polycystic ovary syndrome 9 (36.0) 11 (35.5) 0.0016 0.9680 7 (35.0) 9 (33.3) 0.0142 0.9051
Hypertension 7 (28.0) 10 (32.3) 0.1187 0.7305 6 (30.0) 7 (25.9) 0.0953 0.7575
Diabetes mellitus 6 (24.0) 8 (25.8) 0.0241 0.8767 5 (25.0) 6 (22.2) 0.0495 0.8240
Family history of cancer 2 (8.0) 5 (16.1) 0.8361 0.3605 1 (5.0) 3 (11.1) 0.5511 0.4579
Insulin resistance 12 (48.0) 16 (51.6) 0.0723 0.7881 10 (50.0) 13 (48.1) 0.0158 0.9001